[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [Pharmacology](https://durgical.com/en/pharmacology/) › [Loop diuretics](https://durgical.com/en/pharmacology/classes/loop-diuretics/) › Furosemide [Pharmacology](https://durgical.com/en/pharmacology/) · [Loop diuretics](https://durgical.com/en/pharmacology/classes/loop-diuretics/) # Furosemide The most used loop diuretic: it removes fluid quickly in heart failure, pulmonary oedema and other oedemas, and lowers potassium. Updated 2026-11-01 - Class: [Loop diuretics](https://durgical.com/en/pharmacology/classes/loop-diuretics/) - Transporter: Na⁺-K⁺-2Cl⁻ cotransporter (NKCC2) of the loop of Henle - ATC code: C03CA01 - WHO Model List of Essential Medicines Also called: Frusemide ⇄**Na⁺-K⁺-2Cl⁻ cotransporter (NKCC2) of the loop of Henle**Furosemide ⓘ The figure shows furosemide bound to human NKCC1, the closely related cotransporter found outside the kidney; NKCC2, the renal target, belongs to the same family and binds loop diuretics in the same way. **Target in 3D:** Na⁺-K⁺-2Cl⁻ cotransporter (NKCC2) of the loop of Henle. PDB structure 9C0E (RCSB PDB, public domain). [View the structure at RCSB PDB](https://www.rcsb.org/structure/9C0E) · Drag to rotate · pinch to zoom ## Mechanism of action Furosemide is secreted into the tubule by the proximal tubule's organic acid transporters and, from the lumen, blocks NKCC2 in the thick ascending limb. Sodium, potassium and chloride are not reabsorbed, the medullary concentration gradient falls and a large volume of urine follows. Loss of the lumen-positive voltage also increases calcium and magnesium excretion. Given IV it also dilates veins, which helps in pulmonary oedema. - Furosemide reaches the tubule lumen by secretion - It blocks NKCC2 in the thick ascending limb - Na⁺, K⁺ and Cl⁻ stay in the urine and water follows - Rapid diuresis; more K⁺, Mg²⁺ and Ca²⁺ are lost ## Pharmacokinetics **Absorption** Absorbed by mouth, but only partly and variably; the IV route gives a faster, larger effect **Distribution** Highly bound to albumin; low albumin (nephrotic syndrome) weakens its effect **Metabolism** Partly conjugated to a glucuronide **Elimination** Mostly unchanged in the urine; it accumulates in kidney failure **Half-life** About 2 hours **Onset and duration** IV: diuresis within about 5 minutes, peak within half an hour, lasting about 2 hours ## Indications - Oedema from heart failure [Heart failure →](https://durgical.com/en/conditions/heart-failure/) - Oedema and ascites in cirrhosis (with spironolactone) [Cirrhosis →](https://durgical.com/en/conditions/cirrhosis/) - Oedema in kidney disease, including nephrotic syndrome [Chronic kidney disease →](https://durgical.com/en/conditions/chronic-kidney-disease/) - Acute pulmonary oedema (IV) - Hypertension, especially with kidney failure or fluid overload [Arterial hypertension →](https://durgical.com/en/conditions/arterial-hypertension/) ## Adverse effects ### Common - Excessive diuresis, dehydration and low blood pressure on standing - Hypokalaemia, hypomagnesaemia and hypocalcaemia - Hyponatraemia and metabolic alkalosis - High uric acid and gout - Higher blood glucose - Photosensitivity ### Serious (rare, important) - Ototoxicity: tinnitus, hearing loss, sometimes permanent - Volume depletion with kidney injury and, in older adults, thrombosis - Arrhythmias from low potassium or magnesium - Severe skin reactions and blood disorders (rare) ## Contraindications - Anuria - Hypersensitivity to furosemide (possible cross-reaction in sulfonamide allergy) - Hepatic coma or severe electrolyte depletion until corrected ## Key interactions **Aminoglycosides, cisplatin or etacrynic acid** More ototoxicity **Lithium** Less lithium clearance and risk of lithium toxicity **Digoxin** Low potassium and magnesium increase digoxin toxicity **NSAIDs (e.g. indometacin)** Weaker diuretic and antihypertensive effect, and risk of kidney injury **ACE inhibitors or ARBs** Marked hypotension and worsening kidney function ## What is monitored - Potassium, sodium, magnesium and calcium - Creatinine and urea - Weight, fluid balance and urine output - Blood pressure, including on standing - Hearing at high IV doses - Blood glucose and uric acid ## Administration and safety - Given by mouth, IV or IM; the IV dose is injected slowly or infused, because fast injection raises the risk of ototoxicity. - Protect the solution from light; do not use it if discoloured. - It is alkaline and can precipitate when mixed with acidic solutions: check compatibility before adding it to a line. - Give earlier in the day to avoid night-time urination. ## Nursing care - Before giving: blood pressure, potassium and kidney function; hold and report if potassium is low or the patient is hypotensive. - Daily weight at the same time, intake and output, and signs of oedema or dehydration. - Watch for low potassium (weakness, cramps, arrhythmias) and digoxin toxicity in patients on digoxin. - Ask about tinnitus or hearing loss, especially with IV use or aminoglycosides. - Teach: rise slowly to avoid dizziness, protect the skin from the sun, report thirst, cramps or reduced urine. ## Pregnancy and breastfeeding Not a usual treatment in pregnancy; it crosses the placenta and fetal growth is monitored if it is used. ## Memory aid Furosemide floods the loop: it blocks the NKCC2 "triple door" and K⁺, Mg²⁺ and Ca²⁺ wash out with the water; rush the IV and the ears ring. ## Test yourself Think of the answer, then tap the question to see it. ## Where and on what does furosemide act? On the Na⁺-K⁺-2Cl⁻ cotransporter (NKCC2) in the thick ascending limb of the loop of Henle, reaching it from the tubule lumen. ## Can you name four electrolyte changes furosemide can cause? Hypokalaemia, hypomagnesaemia, hypocalcaemia and hyponatraemia, plus hypochloraemic metabolic alkalosis. ## Which drug combination increases furosemide's ototoxicity? Aminoglycosides, cisplatin or etacrynic acid, especially with fast IV injection or kidney failure. ## Why do NSAIDs reduce the effect of furosemide? They block prostaglandin synthesis in the kidney, which reduces renal blood flow and the natriuretic response to the diuretic. [Add to my cards (4)](https://durgical.app/estudiar/?add=/en/pharmacology/furosemide/) ## Related drugs - [Hydrochlorothiazide](https://durgical.com/en/pharmacology/hydrochlorothiazide/) - [Spironolactone](https://durgical.com/en/pharmacology/spironolactone/) ## Related conditions - [Heart failure](https://durgical.com/en/conditions/heart-failure/) - [Cirrhosis](https://durgical.com/en/conditions/cirrhosis/) - [Chronic kidney disease](https://durgical.com/en/conditions/chronic-kidney-disease/) - [Arterial hypertension](https://durgical.com/en/conditions/arterial-hypertension/) [← Back to the class: Loop diuretics](https://durgical.com/en/pharmacology/classes/loop-diuretics/) Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given. Sources: [DailyMed - FUROSEMIDE injection, solution](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2590ebb6-ce2a-4e23-9244-e54e3010d488) (DailyMed (U.S. National Library of Medicine), 2026); [Furosemide: MedlinePlus Drug Information](https://medlineplus.gov/druginfo/meds/a682858.html) (MedlinePlus (U.S. National Library of Medicine), 2025); [ATCDDD - ATC/DDD Index](https://atcddd.fhi.no/atc_ddd_index/?code=C03CA01) (WHO Collaborating Centre for Drug Statistics Methodology, 2026); [eEML - Electronic Essential Medicines List](https://list.essentialmeds.org/) (World Health Organization, 2025). ## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake Representative model, for educational purposes only. --- Source: https://durgical.com/en/pharmacology/furosemide/ License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/pharmacology/furosemide/